Literature DB >> 27492758

Minority groups and the artificial pancreas: who is (not) in line?

Lauren Huyett1, Eyal Dassau2, Jordan E Pinsker3, Francis J Doyle2, David Kerr4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27492758     DOI： 10.1016/S2213-8587(16)30144-9

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  6 in total

1.  Rethinking the Endpoints of mHealth Intervention Research in Diabetes Care.

Authors:  Katherine L Modzelewski; Mary-Catherine Stockman; Devin W Steenkamp
Journal:  J Diabetes Sci Technol       Date:  2017-09-27

2.  Real-World Evidence Should Be Used in Regulatory Decisions About New Pharmaceutical and Medical Device Products for Diabetes.

Authors:  David C Klonoff; Alberto Gutierrez; Alexander Fleming; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2019-04-03

3.  Overcoming Barriers to Adoption of Digital Health Tools for Diabetes.

Authors:  David C Klonoff; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2017-10-03

4.  Clouds and Silver Linings: COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through Telehealth.

Authors:  David Kerr; Hope Warshaw
Journal:  J Diabetes Sci Technol       Date:  2020-10-13

5.  Digital Diabetes Data and Artificial Intelligence: A Time for Humility Not Hubris.

Authors:  David Kerr; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2018-09-05

Review 6.  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.

Authors:  Eleni Bekiari; Konstantinos Kitsios; Hood Thabit; Martin Tauschmann; Eleni Athanasiadou; Thomas Karagiannis; Anna-Bettina Haidich; Roman Hovorka; Apostolos Tsapas
Journal:  BMJ       Date:  2018-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.